EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN

G. Latkovskis; N. Licis; B. Krivmane; E. Liepins; M. Dambrova; I. Urtane; A. Knipse; M. Zabunova; M. Berzina; A. Erglis

EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN

G. Latkovskis
, N. Licis
, B. Krivmane
, E. Liepins
, M. Dambrova
, I. Urtane
, A. Knipse
, M. Zabunova
, M. Berzina
, A. Erglis

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	520
Pages (from-to)	110-111
Journal	Atherosclerosis Supplements
Volume	12
Issue number	1
Publication status	Published - Jun 2011
Event	79th Congress of the European Atherosclerosis Society (EAS) - Gothenburg, Sweden Duration: 26 Jun 2011 → 29 Jun 2011 Conference number: 79 https://www.medscape.com/viewcollection/32070

Field of Science*

3.2 Clinical medicine
3.1 Basic medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

https://www.sciencedirect.com/science/article/abs/pii/S1567568811705219

Cite this

Latkovskis, G., Licis, N., Krivmane, B., Liepins, E., Dambrova, M., Urtane, I., Knipse, A., Zabunova, M., Berzina, M., & Erglis, A. (2011). EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN. Atherosclerosis Supplements, 12(1), 110-111. Article 520. https://www.sciencedirect.com/science/article/abs/pii/S1567568811705219

@article{1a450203f17740858a64d9de239aad6c,

title = "EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN",

author = "G. Latkovskis and N. Licis and B. Krivmane and E. Liepins and M. Dambrova and I. Urtane and A. Knipse and M. Zabunova and M. Berzina and A. Erglis",

year = "2011",

month = jun,

language = "English",

volume = "12",

pages = "110--111",

journal = "Atherosclerosis Supplements",

issn = "1567-5688",

publisher = "Elsevier Ireland Ltd",

number = "1",

note = "79th Congress of the European Atherosclerosis Society (EAS), EAS 2011 ; Conference date: 26-06-2011 Through 29-06-2011",

url = "https://www.medscape.com/viewcollection/32070",

}

Latkovskis, G, Licis, N, Krivmane, B, Liepins, E , Dambrova, M , Urtane, I, Knipse, A, Zabunova, M, Berzina, M & Erglis, A 2011, 'EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN', Atherosclerosis Supplements, vol. 12, no. 1, 520, pp. 110-111. <https://www.sciencedirect.com/science/article/abs/pii/S1567568811705219>

TY - JOUR

T1 - EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN

AU - Latkovskis, G.

AU - Licis, N.

AU - Krivmane, B.

AU - Liepins, E.

AU - Dambrova, M.

AU - Urtane, I.

AU - Knipse, A.

AU - Zabunova, M.

AU - Berzina, M.

AU - Erglis, A.

N1 - Conference code: 79

PY - 2011/6

Y1 - 2011/6

UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:000300159000516

M3 - Meeting Abstract

SN - 1567-5688

VL - 12

SP - 110

EP - 111

JO - Atherosclerosis Supplements

JF - Atherosclerosis Supplements

IS - 1

M1 - 520

T2 - 79th Congress of the European Atherosclerosis Society (EAS)

Y2 - 26 June 2011 through 29 June 2011

ER -

EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this